227 related articles for article (PubMed ID: 29390581)
1. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.
Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE
Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analysis of 46 cases with CD4
Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
[TBL] [Abstract][Full Text] [Related]
3. A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor.
Egger A; Coello D; Kirsner RS; Brehm JE
J Drugs Dermatol; 2021 May; 20(5):550-551. PubMed ID: 33938687
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K
Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093
[TBL] [Abstract][Full Text] [Related]
5. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F
Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824
[TBL] [Abstract][Full Text] [Related]
6. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
[TBL] [Abstract][Full Text] [Related]
7. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
[TBL] [Abstract][Full Text] [Related]
8. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract][Full Text] [Related]
9. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
Cheng W; Yu TT; Tang AP; He Young K; Yu L
Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case report.
Szablewski V; Costes V; Bret C; Dereure O; Yosr H; Alame M; Cacheux V
J Cutan Pathol; 2018 Aug; 45(8):610-614. PubMed ID: 29660158
[TBL] [Abstract][Full Text] [Related]
11. Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review.
Wang Q; Zhao Y; Zang X; Zhou G; Liu Y; Feng Q; Li X; Wang W; Dong X; Liu X; Peng J; Liu C
Ann Hematol; 2024 Mar; 103(3):999-1005. PubMed ID: 38285081
[TBL] [Abstract][Full Text] [Related]
12. Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.
Sugimoto KJ; Shimada A; Yamaguchi N; Imai H; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2013; 6(11):2603-8. PubMed ID: 24228127
[TBL] [Abstract][Full Text] [Related]
13. A CD56- immunoblastoid variant of blastic plasmacytoid dendritic cell neoplasm.
Aran BM; Duran J; Whittemore D; Gru AA
J Cutan Pathol; 2024 Jan; 51(1):40-44. PubMed ID: 37612885
[TBL] [Abstract][Full Text] [Related]
14. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
Li Y; Li Z; Lin HL; Chen XH; Li B
Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia.
Khan AM; Munir A; Raval M; Mehdi S
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31308179
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm of the breast: A case report and review of the literature.
Lee HJ; Park HM; Ki SY; Choi YD; Yun SJ; Lim HS
Medicine (Baltimore); 2021 May; 100(19):e25699. PubMed ID: 34106594
[TBL] [Abstract][Full Text] [Related]
19. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH
Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]